Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis.
Brownlee WJ, Vidal-Jordana A, Shatila M, Strijbis E, Schoof L, Killestein J, Barkhof F, Bollo L, Rovira A, Sastre-Garriga J, Tintore M, Rocca MA, Esposito F, Azzimonti M, Filippi M, Bodini B, Lazzarotto A, Stankoff B, Montalban X, Toosy AT, Thompson AJ, Ciccarelli O; MAGNIMS Study Group. Brownlee WJ, et al. Among authors: shatila m. Ann Neurol. 2024 Nov 28. doi: 10.1002/ana.27145. Online ahead of print. Ann Neurol. 2024. PMID: 39605172
Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.
Shatila M, Zhang HC, Shirwaikar Thomas A, Machado AP, Naz S, Mittal N, Catinis C, Varatharajalu K, Colli Cruz C, Lu E, Wu D, Brahmer JR, Carbonnel F, Hanauer SB, Lashner B, Schneider B, Thompson JA, Obeid M, Farris DP, Wang Y. Shatila M, et al. J Immunother Cancer. 2024 Nov 14;12(11):e009742. doi: 10.1136/jitc-2024-009742. J Immunother Cancer. 2024. PMID: 39542654 Free PMC article.
Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trial.
Williams T, John N, Calvi A, Bianchi A, De Angelis F, Doshi A, Wright S, Shatila M, Yiannakas MC, Chowdhury F, Stutters J, Ricciardi A, Prados F, MacManus D, Grussu F, Karsa A, Samson B, Battiston M, Gandini Wheeler-Kingshott CAM, Shmueli K, Ciccarelli O, Barkhof F, Chataway J; UCL MS-STAT2 investigators. Williams T, et al. Among authors: shatila m. Neuroimage Rep. 2024 Sep;4(3):100216. doi: 10.1016/j.ynirp.2024.100216. Neuroimage Rep. 2024. PMID: 39328985 Free PMC article.
Response.
Shatila M, Wang Y. Shatila M, et al. Gastrointest Endosc. 2024 Aug;100(2):349-350. doi: 10.1016/j.gie.2024.03.029. Gastrointest Endosc. 2024. PMID: 39025603 No abstract available.
Gastrointestinal toxicities of proteasome inhibitor therapy.
Shah J, Devalaraju S, Baerman E, Lee IJ, Takigawa K, Machado AP, Catinis C, Shatila M, Varatharajalu K, Shafi M, Lee HC, Strati P, Thomas A, Wang Y. Shah J, et al. Among authors: shatila m. J Cancer Res Clin Oncol. 2024 Jul 5;150(7):334. doi: 10.1007/s00432-024-05716-3. J Cancer Res Clin Oncol. 2024. PMID: 38969842 Free PMC article.
42 results